Results 231 to 240 of about 16,419,568 (354)

Hepatitis B virus pre‐S mutants, endoplasmic reticulum stress and hepatocarcinogenesis

Cancer Science, 2006
Hui-Ching Wang, Wen-Ya Huang, M. Lai, Ih-jen Su   +3 more
semanticscholar   +1 more source

Epigenetic Regulation of Liver Fibrosis: Mechanisms and Therapeutic Implications

Portal Hypertension &Cirrhosis, EarlyView.
This review synthesizes the epigenetic mechanisms—DNA methylation, histone modifications, and non‐coding RNAs—that drive hepatic stellate cell activation and the progression of liver fibrosis. It further evaluates emerging therapeutic strategies targeting these epigenetic regulators, including DNA methyltransferase and histone deacetylase inhibitors ...
Maryam Jadid Tavaf, Mahboobeh Ebrahimi Varkiani, Saeid Abroun, Pedram Asadi‐Sarabi, Shukoofeh Torabi, Elham Rismani, Mohammad Majd Hammour, Andreas K. Nüssler, Massoud Vosough   +8 more
wiley   +1 more source

Progress and challenge of hepatitis B virus mucosal vaccines. [PDF]

Virol J
Renxuan J, Hongxiang L, Daru L.
europepmc   +1 more source

Recompensation of Cirrhosis: A New Treatment‐Related Disease State

Portal Hypertension &Cirrhosis, EarlyView.
This perspective article conceptualizes recompensation of cirrhosis as a distinct treatment‐related disease state rather than mere transient clinical improvement after etiology‐directed therapy, and further proposes a four‐state classification including compensated cirrhosis, stable recompensation, unstable recompensation, and persistent decompensation
Wentao Tan, Zhiying He, Shuai Xia, Luqi Tang, Hong You, Bingqiong Wang   +5 more
wiley   +1 more source

Sequential combination of anti-PD-1 antibody and PEG-IFNα in chronic hepatitis B patients: correlates of HBsAg loss with enhanced T-cell responses. [PDF]

Emerg Microbes Infect
Wang H, Zhang C, Li X, Li Y, Zhang X, Xu R, Wang K, Lv S, Fan X, Wang Q, Liu S, Yang S, Zhang X, Dang S, Wang FS, Fu J.   +15 more
europepmc   +1 more source

Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells

Journal of Virology, 1993
Chwen-Ming Shih, Szecheng J. Lo, T. Miyamura, Shiow-Yi Chen, Yan-Hwa Wu Lee   +4 more
semanticscholar   +1 more source

The Emerging Role of China in the Innovation, Individualization, and Translation of Antiviral Therapeutics for Chronic Hepatitis B

Portal Hypertension &Cirrhosis, EarlyView.
This perspective outlines China's contributions toward functional‐cure‐oriented antiviral therapies for chronic hepatitis B, summarizing key clinical data on bepirovirsen and domestic drug pipelines with balanced coverage of both promising and disappointing trial results.
Dandan Weng, Zhujun Cao, Qing Xie
wiley   +1 more source

Risk factors for postpartum alanine aminotransferase elevation in women with chronic hepatitis B infection: a systematic review and meta-analysis. [PDF]

Front Public Health
Yao C, Gao X, Zhu Y, Zhang X, Dai S, Wang J, Chen Y, Zou H.   +7 more
europepmc   +1 more source

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

Proceedings of the National Academy of Sciences of the United States of America, 1995
Y. Thanavala, Y.-F. Yang, P. Lyons, H. Mason, C. Arntzen   +4 more
semanticscholar   +1 more source

Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 420-434, March 2025.
ABSTRACT Chronic Hepatitis B presents a significant health and socioeconomic burden. The risk of hepatocellular carcinoma remains elevated although treatments are available. Achieving an optimal treatment regimen necessitates a deep comprehension of the dynamic relationship between the virus and its host across disease states.
Clémence Boivin‐Champeaux, Nieves Velez de Mendizabal, Aksana Jones, Scott Balsitis, Stephan Schmidt, Justin S. Feigelman, Francine Johansson Azeredo   +6 more
wiley   +1 more source